Related Experiment Video
Updated: Aug 8, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
The monitoring of inflammation by specific cellular markers
1Department of Clinical Chemistry, University Hospital, Uppsala.
Insights
New assays measuring unique inflammatory cell markers offer more sensitive detection of disease activity than traditional methods. Human neutrophil lipocalin (HNL) shows promise in differentiating bacterial and viral infections.
Area of Science:
- Clinical immunology
- Biomarker discovery
- Inflammatory disease diagnostics
Background:
- Current inflammatory disease evaluation relies on conventional methods with limited sensitivity.
- Established markers include eosinophil cationic protein (ECP) for asthma and neutrophil markers (myeloperoxidase, elastase) for infections and extracorporeal circulation.
- There is a need for more sensitive and specific biomarkers for inflammatory conditions.
Purpose of the Study:
- To explore the potential of unique secretory components from inflammatory cells as novel biomarkers.
- To evaluate the diagnostic and pathophysiological utility of these cellular markers.
- To highlight advancements in inflammatory disease monitoring through novel assays.
Main Methods:
- Measurement of specific secretory proteins from inflammatory cells, including eosinophil cationic protein (ECP).
- Analysis of neutrophil markers such as myeloperoxidase, elastase, and human neutrophil lipocalin (HNL).
- Serum level assessment of these markers for clinical evaluation.
Main Results:
- Specific cellular markers demonstrate higher sensitivity in detecting inflammatory activity compared to conventional methods.
- ECP is extensively used for evaluating lung inflammation in asthmatics.
- Human neutrophil lipocalin (HNL) shows superior performance in distinguishing between acute bacterial and viral infections.
Conclusions:
- Unique cellular markers provide valuable pathophysiological insights beyond mere detection of inflammatory activity.
- Novel assays for inflammatory cell components represent a significant advancement in diagnosing and monitoring inflammatory diseases.
- The development of a panel of unique cellular markers holds promise for future clinical applications in personalized medicine.
Abstract:
The use of specific assays for unique secretory components of various inflammatory cells in the clinical evaluation of inflammatory diseases is a new and fascinating possibility, since these assays seem to be more sensitive indicators of inflammatory activity than the conventionally used methods and since these unique cellular markers in addition provide us with useful pathophysiological information. So far the most widely used markers are eosinophil cationic protein (ECP) from the eosinophil and neutrophil markers such as myeloperoxidase and elastase. Serum measurements of the former are used quite extensively in the evaluation of the inflammatory process in the lung of asthmatics whereas the latter predominantly are used in relation to bacterial infections and as compatibility markers in relation to extracorporeal circulation. Recent developments have shown that the serum measurement of a new protein from the neutrophil, human neutrophil lipocalin (HNL), is a superior means to distinguish acute bacterial and viral infections. The future access to a panel of unique cellular markers of inflammatory cells will undoubtedly reveal new exciting possibilities in the diagnosis and therapeutic monitoring of patients with inflammatory diseases.
More Related Videos
Related Concept Videos
Inflammation
Inflammatory Response I: Vascular and Cellular
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Cellular Phase
Chronic Inflammation: Introduction

